CZ20014163A3 - Deriváty purinu, způsob jejich přípravy a farmaceutické kompozice tyto deriváty obsahující - Google Patents

Deriváty purinu, způsob jejich přípravy a farmaceutické kompozice tyto deriváty obsahující Download PDF

Info

Publication number
CZ20014163A3
CZ20014163A3 CZ20014163A CZ20014163A CZ20014163A3 CZ 20014163 A3 CZ20014163 A3 CZ 20014163A3 CZ 20014163 A CZ20014163 A CZ 20014163A CZ 20014163 A CZ20014163 A CZ 20014163A CZ 20014163 A3 CZ20014163 A3 CZ 20014163A3
Authority
CZ
Czechia
Prior art keywords
radical
formula
radicals
carbon atoms
phenyl
Prior art date
Application number
CZ20014163A
Other languages
Czech (cs)
English (en)
Inventor
Jean-Luc Haesslein
Original Assignee
Aventis Pharma S. A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma S. A. filed Critical Aventis Pharma S. A.
Publication of CZ20014163A3 publication Critical patent/CZ20014163A3/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/16Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/24Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one nitrogen and one sulfur atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Dermatology (AREA)
  • Psychiatry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CZ20014163A 1999-05-21 2000-05-18 Deriváty purinu, způsob jejich přípravy a farmaceutické kompozice tyto deriváty obsahující CZ20014163A3 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9906456A FR2793794B1 (fr) 1999-05-21 1999-05-21 Nouveaux derives de la purine, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation

Publications (1)

Publication Number Publication Date
CZ20014163A3 true CZ20014163A3 (cs) 2002-10-16

Family

ID=9545846

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ20014163A CZ20014163A3 (cs) 1999-05-21 2000-05-18 Deriváty purinu, způsob jejich přípravy a farmaceutické kompozice tyto deriváty obsahující

Country Status (33)

Country Link
US (2) US7122669B1 (https=)
EP (1) EP1183256B1 (https=)
JP (1) JP2003500407A (https=)
KR (1) KR100707895B1 (https=)
CN (1) CN1298719C (https=)
AP (1) AP1477A (https=)
AR (1) AR035317A1 (https=)
AT (1) ATE370951T1 (https=)
AU (1) AU4764500A (https=)
BR (1) BR0011282A (https=)
CA (1) CA2374714A1 (https=)
CZ (1) CZ20014163A3 (https=)
DE (1) DE60036102T2 (https=)
DK (1) DK1183256T3 (https=)
DZ (1) DZ3166A1 (https=)
EA (1) EA005072B1 (https=)
ES (1) ES2290033T3 (https=)
FR (1) FR2793794B1 (https=)
HU (1) HUP0201649A3 (https=)
IL (1) IL146441A0 (https=)
MA (1) MA26791A1 (https=)
MX (1) MXPA01011834A (https=)
NO (1) NO20015659L (https=)
NZ (1) NZ515556A (https=)
PL (1) PL352293A1 (https=)
PT (1) PT1183256E (https=)
SK (1) SK16722001A3 (https=)
TR (1) TR200103349T2 (https=)
TW (1) TWI284130B (https=)
UA (1) UA68441C2 (https=)
WO (1) WO2000071543A1 (https=)
YU (1) YU86601A (https=)
ZA (1) ZA200109602B (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ302122B6 (cs) * 2009-01-28 2010-10-20 Univerzita Palackého v Olomouci Substituované deriváty 6-(2-aminobenzylamino)purinu, jejich použití jako léciva a prípravky tyto slouceniny obsahující

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6413974B1 (en) * 1998-02-26 2002-07-02 Aventis Pharmaceuticals Inc. 6,9,-disubstituted 2-[trans-(4-aminocyclohexyl) amino] purines
US6479487B1 (en) * 1998-02-26 2002-11-12 Aventis Pharmaceuticals Inc. 6, 9-disubstituted 2-[trans-(4-aminocyclohexyl)amino] purines
US6969720B2 (en) 1999-03-17 2005-11-29 Amr Technology, Inc. Biaryl substituted purine derivatives as potent antiproliferative agents
AU3938802A (en) * 2000-10-31 2002-06-03 Aventis Pharma Inc Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents
US6861524B2 (en) * 2000-10-31 2005-03-01 Aventis Pharmaceuticals Inc. Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents
FR2818642B1 (fr) * 2000-12-26 2005-07-15 Hoechst Marion Roussel Inc Nouveaux derives de la purine, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilistion
US6812232B2 (en) 2001-09-11 2004-11-02 Amr Technology, Inc. Heterocycle substituted purine derivatives as potent antiproliferative agents
US6667311B2 (en) * 2001-09-11 2003-12-23 Albany Molecular Research, Inc. Nitrogen substituted biaryl purine derivatives as potent antiproliferative agents
EP1578722A4 (en) * 2001-10-12 2006-09-06 Irm Llc KINASEINHIBITOR SCAFFOLD AND METHOD FOR THE PRODUCTION THEREOF
WO2004035132A2 (en) * 2002-10-15 2004-04-29 Irm Llc Compositions and methods for inducing osteogenesis
FR2851248B1 (fr) * 2003-02-18 2005-04-08 Aventis Pharma Sa Nouveaux derives de la purine, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation
US7951592B2 (en) * 2003-11-10 2011-05-31 The Scripps Research Institute Compositions and methods for inducing cell dedifferentiation
CA2563123A1 (en) * 2004-04-02 2005-10-20 Adenosine Therapeutics, Llc Selective antagonists of a2a adenosine receptors
WO2012142029A2 (en) 2011-04-10 2012-10-18 Florida A&M University Serms for the treatment of estrogen receptor-mediated disorders
EP3134405B1 (en) 2014-04-25 2019-08-28 Pfizer Inc Heteroaromatic compounds and their use as dopamine d1 ligands
CN114149432B (zh) * 2016-09-30 2024-07-05 斯坦福国际研究院 用于癌症治疗的双重clk/cdk1抑制剂
CZ308029B6 (cs) * 2017-03-20 2019-11-06 Univerzita PalackĂ©ho v Olomouci 2,6-Disubstituované-9-cyklopentyl-9H-puriny, jejich použití jako léčiva a farmaceutické přípravky
JP2026500305A (ja) 2022-12-16 2026-01-06 アストラゼネカ・アクチエボラーグ 2,6,9三置換プリン

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4008858A1 (de) * 1990-03-20 1991-09-26 Hoechst Ag Substituierte purine, verfahren zu ihrer hertellung sowie ihre verwendung als antivirale mittel
EP0841810B1 (en) * 1991-12-05 2000-06-21 Texas Instruments Incorporated Method to improve a video signal
CA2084222C (en) * 1991-12-06 2004-04-06 David R. Borcherding Novel trans cyclopentanyl purine analogs useful as immunosuppressants
BR9611157A (pt) * 1995-11-01 1999-03-30 Novartis Ag Derivados de purina e processos para sua preparação
FR2741881B1 (fr) * 1995-12-01 1999-07-30 Centre Nat Rech Scient Nouveaux derives de purine possedant notamment des prorietes anti-proliferatives et leurs applications biologiques
US5866702A (en) * 1996-08-02 1999-02-02 Cv Therapeutics, Incorporation Purine inhibitors of cyclin dependent kinase 2
US6790958B2 (en) * 1996-08-02 2004-09-14 Robert T. Lum Purine inhibitors of cyclin dependent kinase 2 & IKBA
AU4920397A (en) * 1996-10-11 1998-05-11 Chiron Corporation Purine inhibitors of glycogen synthase kinase 3 (gsk3)
CA2297967A1 (en) * 1997-08-07 1999-02-18 The Regents Of The University Of California Purine inhibitor of protein kinases, g proteins and polymerases
US6479487B1 (en) * 1998-02-26 2002-11-12 Aventis Pharmaceuticals Inc. 6, 9-disubstituted 2-[trans-(4-aminocyclohexyl)amino] purines
US6413974B1 (en) * 1998-02-26 2002-07-02 Aventis Pharmaceuticals Inc. 6,9,-disubstituted 2-[trans-(4-aminocyclohexyl) amino] purines
GB9903762D0 (en) * 1999-02-18 1999-04-14 Novartis Ag Organic compounds
FR2818642B1 (fr) * 2000-12-26 2005-07-15 Hoechst Marion Roussel Inc Nouveaux derives de la purine, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilistion

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ302122B6 (cs) * 2009-01-28 2010-10-20 Univerzita Palackého v Olomouci Substituované deriváty 6-(2-aminobenzylamino)purinu, jejich použití jako léciva a prípravky tyto slouceniny obsahující

Also Published As

Publication number Publication date
SK16722001A3 (sk) 2003-01-09
CN1298719C (zh) 2007-02-07
PT1183256E (pt) 2007-11-13
JP2003500407A (ja) 2003-01-07
MXPA01011834A (es) 2002-04-17
EP1183256A1 (fr) 2002-03-06
KR20010113975A (ko) 2001-12-28
DE60036102D1 (de) 2007-10-04
IL146441A0 (en) 2002-07-25
CN1361780A (zh) 2002-07-31
FR2793794A1 (fr) 2000-11-24
ATE370951T1 (de) 2007-09-15
NZ515556A (en) 2003-08-29
CA2374714A1 (fr) 2000-11-30
DE60036102T2 (de) 2008-05-15
YU86601A (sh) 2005-07-19
US7122669B1 (en) 2006-10-17
EA005072B1 (ru) 2004-10-28
BR0011282A (pt) 2002-02-26
DZ3166A1 (fr) 2000-11-30
ES2290033T3 (es) 2008-02-16
NO20015659D0 (no) 2001-11-20
AP1477A (en) 2005-10-19
US7208598B2 (en) 2007-04-24
US20050187228A1 (en) 2005-08-25
AU4764500A (en) 2000-12-12
AR035317A1 (es) 2004-05-12
EP1183256B1 (fr) 2007-08-22
HUP0201649A2 (en) 2002-08-28
WO2000071543A1 (fr) 2000-11-30
EA200101224A1 (ru) 2002-10-31
TR200103349T2 (tr) 2002-05-21
AP2001002355A0 (en) 2001-12-31
KR100707895B1 (ko) 2007-04-17
TWI284130B (en) 2007-07-21
MA26791A1 (fr) 2004-12-20
ZA200109602B (en) 2003-01-29
UA68441C2 (en) 2004-08-16
HUP0201649A3 (en) 2003-01-28
PL352293A1 (en) 2003-08-11
FR2793794B1 (fr) 2001-07-27
DK1183256T3 (da) 2007-12-03
NO20015659L (no) 2002-01-18

Similar Documents

Publication Publication Date Title
CZ20014163A3 (cs) Deriváty purinu, způsob jejich přípravy a farmaceutické kompozice tyto deriváty obsahující
EP3565815B1 (en) Compounds as bcl-2-selective apoptosis-inducing agents
CN110546151B (zh) 凋亡诱导剂
CA3074459A1 (en) Inhibitors of egfr and/or her2 and methods of use
CN102333764B (zh) 取代的吡咯衍生物、含这些衍生物的药用组合物以及用其治疗帕金森氏病的方法
AU2019245390B2 (en) Mono-(acid) salts of 6-aminoisoquinolines and uses thereof
JP2018521092A (ja) ヒストン脱アセチル化酵素6阻害剤としての1,3,4−オキサジアゾールスルファミド誘導体化合物及びこれを含有する薬剤学的組成物(1,3,4−Oxadiazole Sulfamide Derivative Compounds as Histone Deacetylase 6 Inhibitor, and the Pharmaceutical Composition Comprising the same)
FR2820136A1 (fr) Nouveaux derives de l'uree, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation
US20170137387A1 (en) Pharmacologically active quinazolinedione derivatives
CN105585565B (zh) 含2-苯胺基-4-噻唑基吡啶衍生物及其制法和药物组合物与用途
SA99191012B1 (ar) مشتقات حمض فينيل أمينو ألكيل كربوكسيلي phenyl amino alkyl carboxylic وتركيبات طبية تشتمل عليها
US20210070742A1 (en) Sulfoximine, sulfonimidamide, sulfondiimine and diimidosulfonamide compounds as inhibitors of indoleamine 2,3-dioxygenase
US20030119876A1 (en) Compounds for the treatment of protozoal diseases
US20100137275A1 (en) Triaminopyrimidine derivatives as inhibitors of cdc25 phosphatase
WO2009018344A1 (en) Anticancer agents
CN105153163A (zh) 2,9-二取代嘌呤-6-氨基异羟肟酸类组蛋白去乙酰化酶抑制剂及制备方法和应用
CN101602750A (zh) (取代)萘基、(取代)芳基、哌嗪基脒类化合物
TWI920639B (zh) Shp2之八氫環戊烷并[c]吡咯別構抑制劑
CN121494842A (zh) 含苯并噻吩的乙酰胺类化合物及其制备方法和应用、药用组合物
HK40098185A (zh) 作为组蛋白脱乙酰酶6抑制剂的1,3,4-恶二唑硫羰基化合物及包含该化合物的药物组合物
AU2006202270A1 (en) Purine derivatives, preparation method and pharmaceutical compositions containing same